ABSTRACT
and establishing the criteria for confident selection of classification rules by applying the reject option technique (RO).
Methods
We evaluated outcome prediction by BFTree, ID3, J48, REPTree, SimpleCART decision-tree algorithms utilizing a 182 patients' dataset. Informed consent was obtained in accordance with institutional policies in use in each country. Fifty percent of the patients were utilized for model selection, and the remaining 50% for independent validation. The risk factors were: NB-hypo, age at diagnosis, stage and MYCN amplification. Accuracy of the classification was measured by Matthew's Correlation Coefficient and assessed by 2 fold cross validation analysis repeated 1000 times. Trade-off between confidence and accuracy was estimated by the RO technique utilizing the accuracy/rejection plot. Kaplan-Meier estimate and log-rank test assessed overall survival.
Results
Every decision tree classified the patients' outcome with a confidence >0.6. Only ID3, utilizing all risk factors, stratified stage 4 patients and was chosen for further analysis. Application of RO raised the ID3 accuracy from 69% to 92%. This result was obtained because of accuracy/rejection plot identified a threshold confidence of 0.66 at which 71% of the patients, classified by highly reliable rules, were accepted. The trade-off was the exclusion from classification of 29% of patients falling in low represented and ambiguous rules. Kaplan-Meier curves showed a significant stratification of stage 4 patients following RO application. In conclusion, we demonstrated that application of the RO improves the classification performance of ID3 decision tree. Stage 4 patients can be stratified in significant groups characterized by the high confidence rules needed for making clinical decisions.
